Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INNOVATIVE SOLUTIONS & SUPPORT INCIA · Entity 544 | Director | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INNOVATIVE SOLUTIONS & SUPPORT INC
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 156,155 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 2,500 · Balance 156,155 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.63 to $19.66, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.63 to $19.66, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Tabula Rasa HealthCare, Inc.
Report date June 15, 2018 · Filed June 19, 2018
Section 16 reporting ended · disclosed 2018-03-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,559 |
Reported balance
After 2018-06-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-06-15 · Grant · Disposed 1,673 · Balance 27,559 F1: The Reporting Person received a restricted stock award of 1,673 shares of the Company's common stock on June 15, 2018. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectAs trustee of family trust | 54,387 |
Reported balance
Holding disclosure · report date 2018-06-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 54,387 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received a restricted stock award of 1,673 shares of the Company's common stock on June 15, 2018. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 20:22 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC IA · Entity 544 | GrantCommon Stock | 2,500 | $19.69 | $49,236.25 |
DisclosureSEC source: 0001104659-26-104747 · tm2624688-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,155 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.63 to $19.66, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| May 20, 2026 Filed May 21, 2026 19:28 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,300 | $15.93 | $100,381.05 |
DisclosureSEC source: 0001104659-26-065110 · tm2615373-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,655 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.88 to $15.95, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 16:32 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantRestricted Stock Units | 5,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-045359 · tm2612234-2_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,355 F1 · shares: The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 17:41 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantRestricted Stock Units | 13,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-036724 · tm2512762-5_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,737 F1 · shares: The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 15:43 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 4,000 | $6.83 | $27,312.00 |
DisclosureSEC source: 0001104659-24-090390 · tm2421907-1_4seq1.xml · nonDerivative · entry 3 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,201 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in 4 transactions at prices ranging from $6.78 to $6.91 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 15:43 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 1,000 | $6.71 | $6,707.00 |
DisclosureSEC source: 0001104659-24-090390 · tm2421907-1_4seq1.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,201 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in 6 transactions at prices ranging from $6.65 to $6.75 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2024 Filed Aug 16, 2024 15:43 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 5,000 | $6.53 | $32,630.00 |
DisclosureSEC source: 0001104659-24-090390 · tm2421907-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,201 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in 15 transactions at prices ranging from $6.40 to $6.66 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 22, 2024 Filed May 23, 2024 20:10 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 2,109 | $5.63 | $11,865.87 |
DisclosureSEC source: 0001104659-24-064689 · tm2415420-1_4seq1.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,201 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in 5 transactions at prices ranging from $5.55 to $5.65 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:10 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 12,891 | $5.55 | $71,542.47 |
DisclosureSEC source: 0001104659-24-064689 · tm2415420-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,092 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in 26 transactions at prices ranging from $5.25 to $5.65 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 20:05 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantRestricted Stock Units | 11,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-049966 · tm2411391-7_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,201 F1 · shares: The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person. Read SEC document |
| April 13, 2024 Filed Apr 17, 2024 01:46 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | Exercise / conversionCommon Stock | 6,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047983 · tm2411391-6_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of shares of Common Stock issued upon the vesting of Restricted Stock Units. F2 · balance_after: On January 29, 2024, the Reporting Person filed Form 4/A and corrected the number of shares of the issuer's common stock directly beneficially owned by the Reporting Person as of May 18, 2023, which was 75,089 shares. The holdings reported on this Form 4 properly give cumulative effect to such correction in the original Form 4 as well as all intervening Forms 4 filed by the Reporting Person prior to the date hereof. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 19:39 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 10,000 | $7.85 | $78,467.00 |
DisclosureSEC source: 0001104659-23-099681 · tm2325896-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,393 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in 3 transactions at prices ranging from $7.78 to $7.85 inclusive. The reporting person undertakes to provide to Innovative Solutions & Support, Inc., any security holder of Innovative Solutions & Support, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 18, 2023 Filed May 27, 2023 00:56 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,319 | $7.15 | $9,430.85 |
DisclosureSEC source: 0001104659-23-065593 · tm2317189-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,755 Read SEC document |
| May 18, 2023 Filed May 31, 2023 01:42 UTC Amendment | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 1,319 | $7.15 | $9,430.85 |
DisclosureSEC source: 0001104659-23-066235 · tm2317189-3_4aseq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,393 F1 · kind: This amended Form 4 is being filed in order to fix an incorrect Transaction Code in the original filing, and also to reflect corresponding updates to Items 4 and 5 of Table I based on the corrected Transaction Code. F1 · acquired: This amended Form 4 is being filed in order to fix an incorrect Transaction Code in the original filing, and also to reflect corresponding updates to Items 4 and 5 of Table I based on the corrected Transaction Code. F1 · balance_after: This amended Form 4 is being filed in order to fix an incorrect Transaction Code in the original filing, and also to reflect corresponding updates to Items 4 and 5 of Table I based on the corrected Transaction Code. Read SEC document |
| May 18, 2023 Filed Jan 29, 2024 21:28 UTC Amendment | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 1,742 | $8.10 | $14,110.20 |
DisclosureSEC source: 0000902959-24-000005 · primary_doc.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,089 F1 · shares: This amended Form 4 is being filed in order to revise an incorrect number of shares and purchase price in the original and amended filings, and also to reflect corresponding updates to Item 5 of Table I. This amendment adjusts the holdings reported on Forms 4 for subsequent transactions. F1 · price: This amended Form 4 is being filed in order to revise an incorrect number of shares and purchase price in the original and amended filings, and also to reflect corresponding updates to Item 5 of Table I. This amendment adjusts the holdings reported on Forms 4 for subsequent transactions. F1 · balance_after: This amended Form 4 is being filed in order to revise an incorrect number of shares and purchase price in the original and amended filings, and also to reflect corresponding updates to Item 5 of Table I. This amendment adjusts the holdings reported on Forms 4 for subsequent transactions. Read SEC document |
| May 16, 2023 Filed Jan 29, 2024 21:18 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 1,319 | $7.21 | $9,509.99 |
DisclosureSEC source: 0000902959-24-000004 · primary_doc.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,347 Read SEC document |
| May 15, 2023 Filed Jan 29, 2024 21:18 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | PurchaseCommon Stock | 3,681 | $7.15 | $26,319.15 |
DisclosureSEC source: 0000902959-24-000004 · primary_doc.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,028 Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 21:23 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-047891 · tm2312625-6_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,074 F1 · security: A portion of the Reporting Person's stock based compensation for the year ended December 31, 2023. In connection with a previously disclosed stock grant on January 3, 2023, the Issuer's Board of Directors determined to make the annual issuance of stock-based compensation to its independent directors in April rather than in January going forward. This grant represents the Reporting Person's stock-based compensation for the period running from January 1, 2023 through April 18, 2023. Read SEC document |
| April 13, 2023 Filed Jan 26, 2024 00:11 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantRestricted Stock Units · Derivative | 6,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000902959-24-000003 · primary_doc.xml · derivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,868 Underlying: Common Stock · 6,868 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock, subject to adjustment as provided in the Award Agreement. F2 · derivative.exercise_date: The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person. F2 · derivative.expiration_date: The RSUs are scheduled to vest on the first anniversary of the grant date, subject to continued service by the reporting person. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:37 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001454 · tm232195-4_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,332 F1 · security: Stock based compensation for the year ended December 31, 2022. In connection with this issuance, the Issuer's Board of Directors determined to make the annual issuance of stock-based compensation to its independent directors in April rather than in January for future periods. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:16 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 15,000 | $9.48 | $142,200.00 |
DisclosureSEC source: 0001104659-22-062453 · tm2215987-1_4seq1.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,244 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.47 to $9.48, inclusive. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:16 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 30,000 | $9.48 | $284,400.00 |
DisclosureSEC source: 0001104659-22-062453 · tm2215987-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,244 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.67, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote or the following footnote to this Form 4. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 23:16 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001047 · tm221460-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,244 F1 · security: Stock based compensation for the year ended December 31, 2021. Read SEC document |
| February 22, 2021 Filed Feb 26, 2021 22:37 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,139 | $6.86 | $7,813.54 |
DisclosureSEC source: 0001104659-21-029420 · tm217565-2_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,895 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.81 to $6.89, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 00:42 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 8,279 | $6.88 | $56,959.52 |
DisclosureSEC source: 0001104659-21-026319 · tm217565-1_4seq1.xml · nonDerivative · entry 4 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,034 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.85 to $6.92, inclusive. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 00:42 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,200 | $6.75 | $8,100.00 |
DisclosureSEC source: 0001104659-21-026319 · tm217565-1_4seq1.xml · nonDerivative · entry 3 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,313 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.76, inclusive. Read SEC document |
| February 17, 2021 Filed Feb 23, 2021 00:42 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 900 | $6.77 | $6,093.00 |
DisclosureSEC source: 0001104659-21-026319 · tm217565-1_4seq1.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,513 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.81, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 23, 2021 00:42 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 6,500 | $6.78 | $44,070.00 |
DisclosureSEC source: 0001104659-21-026319 · tm217565-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,413 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.84, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote or the following footnotes to this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:31 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-001543 · tm211837-2_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,913 F1 · security: Stock based compensation for the year ended December 31, 2020. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 21:45 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 4,276 | $7.80 | $33,352.80 |
DisclosureSEC source: 0001104659-20-138089 · tm2038957-1_4seq1.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,041 Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 01:32 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 18,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-001722 · a4.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,317 F1 · security: Stock based compensation for the year ended December 31, 2019. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:53 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,000 | $4.63 | $4,630.00 |
DisclosureSEC source: 0001179110-19-006489 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,053 Read SEC document |
| May 17, 2019 Filed May 20, 2019 21:14 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 7,445 | $4.60 | $34,247.00 |
DisclosureSEC source: 0001179110-19-006397 · edgar.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,053 Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:14 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 16,555 | $4.66 | $77,146.30 |
DisclosureSEC source: 0001179110-19-006397 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,498 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $4.76, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:00 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 13,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000401 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,053 F1 · security: Stock based compensation for the year ended December 31, 2018. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 15:09 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | GrantCommon Stock | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000305 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,559 F1 · balance_after: The Reporting Person received a restricted stock award of 1,673 shares of the Company's common stock on June 15, 2018. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant. Read SEC document |
| May 17, 2018 Filed May 18, 2018 21:46 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 25,000 | $50.89 | $1,272,250.00 |
DisclosureSEC source: 0001192482-18-000227 · edgar.xml · nonDerivative · entry 3 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · As trustee of family trust Disclosed balance after: 54,387 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.89 to $51.72, inclusive. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:46 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 2,165 | $48.27 | $104,504.55 |
DisclosureSEC source: 0001192482-18-000227 · edgar.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,886 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.15 to $48.49, inclusive. F3 · balance_after: Includes shares received in a pro rata, in-kind distribution to partners by Originate Growth GP, LLC. Such shares had previously been reported as being held indirectly by the Reporting Person through Originate Growth GP, LLC. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:46 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 25,000 | $48.67 | $1,216,750.00 |
DisclosureSEC source: 0001192482-18-000227 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · As trustee of family trust Disclosed balance after: 79,387 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.90 to $49.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (4) to this Form 4. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 23:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 369,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000137 · edgar.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Originate Growth Fund 1A, L.P. Disclosed balance after: 2,544 F1 · kind: Pro rata, in-kind distribution to partners without consideration. F2 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth GP, LLC, Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. F4 · ownership.direct: Includes 2,545 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1A, L.P. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 23:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 816,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000137 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Originate Growth Fund 1Q, L.P. Disclosed balance after: 5,617 F1 · kind: Pro rata, in-kind distribution to partners without consideration. F2 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth GP, LLC, Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. F3 · ownership.direct: Includes 5,616 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1Q, L.P. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:20 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 187,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000096 · edgar.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Originate Growth Fund 1A, L.P. Disclosed balance after: 372,474 F1 · kind: Pro rata, in-kind distribution to partners without consideration. F2 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. F4 · ownership.direct: Includes 2,544 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1A, L.P. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:20 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 412,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000096 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Originate Growth Fund 1Q, L.P. Disclosed balance after: 822,526 F1 · kind: Pro rata, in-kind distribution to partners without consideration. F2 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. F3 · ownership.direct: Includes 5,617 shares originally granted to the Reporting Person by the Issuer as director compensation, which was held for the benefit of Originate Growth Fund #1Q, L.P. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 22:46 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 11,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000382 · edgar.xml · nonDerivative · entry 1 BRESSNER GLEN R · CIK 0000902959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,676 F1 · security: Stock based compensation for the year ended December 31, 2017. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 21:58 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 72,625 | $25.85 | $1,877,356.25 |
DisclosureSEC source: 0001179110-17-015259 · edgar.xml · nonDerivative · entry 4 BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: Originate Growth Fund #1A, L.P. Disclosed balance after: 556,969 F4 · price: Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share. F5 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 21:58 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 160,375 | $25.85 | $4,145,693.75 |
DisclosureSEC source: 0001179110-17-015259 · edgar.xml · nonDerivative · entry 2 BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By: Originate Growth Fund #1Q, L.P. Disclosed balance after: 1,229,898 F2 · price: Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share. F5 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 21:57 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 72,625 | $25.85 | $1,877,356.25 |
DisclosureSEC source: 0001179110-17-015258 · edgar.xml · nonDerivative · entry 2 ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner Arnson Eric R · CIK 0001685942 · 10% owner GAUSLING MICHAEL J · CIK 0001125761 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,969 F2 · price: Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 21:57 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 160,375 | $25.85 | $4,145,693.75 |
DisclosureSEC source: 0001179110-17-015256 · edgar.xml · nonDerivative · entry 2 ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner Arnson Eric R · CIK 0001685942 · 10% owner GAUSLING MICHAEL J · CIK 0001125761 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,229,898 F2 · price: Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis. Read SEC document |
| December 11, 2017 Filed Mar 13, 2018 19:03 UTC Amendment | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 72,625 | $25.85 | $1,877,356.25 |
DisclosureSEC source: 0001192482-18-000108 · edgar.xml · nonDerivative · entry 2 ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · Former 10% owner Originate Growth GP, LLC · CIK 0001685914 · Former 10% owner BRESSNER GLEN R · CIK 0000902959 · Director · Former 10% owner Arnson Eric R · CIK 0001685942 · Former 10% owner GAUSLING MICHAEL J · CIK 0001125761 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,969 F2 · price: Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis. Read SEC document |
| December 11, 2017 Filed Mar 13, 2018 19:03 UTC Amendment | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 160,375 | $25.85 | $4,145,693.75 |
DisclosureSEC source: 0001192482-18-000107 · edgar.xml · nonDerivative · entry 2 ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · Former 10% owner Originate Growth GP, LLC · CIK 0001685914 · Former 10% owner BRESSNER GLEN R · CIK 0000902959 · Director · Former 10% owner Arnson Eric R · CIK 0001685942 · Former 10% owner GAUSLING MICHAEL J · CIK 0001125761 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,229,898 F2 · price: Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.